Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients.
van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ. van Kranenburg M, et al. Among authors: magro m. JACC Cardiovasc Imaging. 2014 Sep;7(9):930-9. doi: 10.1016/j.jcmg.2014.05.010. JACC Cardiovasc Imaging. 2014. PMID: 25212799 Free article. Review.
Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000-2005). Simsek C, et al. Among authors: magro m. Catheter Cardiovasc Interv. 2010 Jul 1;76(1):41-9. doi: 10.1002/ccd.22533. Catheter Cardiovasc Interv. 2010. PMID: 20310019
The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C, Magro M, Boersma E, Onuma Y, Nauta ST, Gaspersz MP, van der Giessen WJ, van Domburg RT, Serruys PW; Interventional Cardiologists of the Thoraxcenter. Simsek C, et al. Among authors: magro m. JACC Cardiovasc Interv. 2010 Oct;3(10):1051-8. doi: 10.1016/j.jcin.2010.08.003. JACC Cardiovasc Interv. 2010. PMID: 20965464 Free article.
Magnetic navigation system assisted stenting of coronary bifurcation lesions.
Simsek C, Magro M, Patterson MS, Onuma Y, Ciampichetti I, van Weenen S, van Domburg RT, Serruys PW, Boersma E, van Geuns RJ. Simsek C, et al. Among authors: magro m. EuroIntervention. 2011 Mar;6(8):970-6. doi: 10.4244/EIJV6I8A168. EuroIntervention. 2011. PMID: 21330245 Clinical Trial.
Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years.
Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Valstar G, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P; Interventional Cardiologists of Thoraxcenter. Simsek C, et al. Among authors: magro m. Catheter Cardiovasc Interv. 2012 Jul 1;80(1):18-26. doi: 10.1002/ccd.23199. Epub 2012 Apr 17. Catheter Cardiovasc Interv. 2012. PMID: 21735520
Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P. Simsek C, et al. Among authors: magro m. J Invasive Cardiol. 2011 Aug;23(8):336-41. J Invasive Cardiol. 2011. PMID: 21828397 Free article.
TheTryton side branch stent.
Magro M, van Geuns RJ. Magro M, et al. EuroIntervention. 2010 Dec;6 Suppl J:J147-50. doi: 10.4244/EIJV6SUPJA25. EuroIntervention. 2010. PMID: 21930481
192 results